丹诺医药（苏州）有限公司

Company Overview

TenNor Therapeutics is a clinical-stage company with a sharp focus on research and development of new drugs to address unmet medical needs in infectious disease area.>>more

2020.06.19

TenNor Was Named as One of the Potential Unicorn Enterprises in Suzhou

TenNor was named as One of the Potential Unicorn Enterprises in Suzhou. Please click here for details：https://www.sohu.com/na/402672110_349645
2020.05.25

TenNor and collaborators publish article on synergistic activity of oxazolidinone-nitroimidazoel conjugates against anaerobic pathogens

Please click here to read the article: /Uploads/file/20200525/20200525092656_20803.pdf
2020.03.20

Investigators from Mayo Clinic Publish Results of TNP-2092 against Periprosthetic Joint Infection-Associated Staphylococci

Please read the article through this link: https://www.sciencedirect.com/science/article/abs/pii/S0732889319307229

Company Overview

TenNor Was Named as One of the Potential Unicorn Enterprises in Suzhou

TenNor and collaborators publish article on synergistic activity of oxazolidinone-nitroimidazoel conjugates against anaerobic pathogens

Investigators from Mayo Clinic Publish Results of TNP-2092 against Periprosthetic Joint Infection-Associated Staphylococci